Wantai Bio invests 550m yuan in structured deposits
Beijing Wantai Biological Pharmacy Enterprise will invest 550 million yuan of idle raised funds in principal-protected structured deposits with annualized yields ranging from 1.20% to 2.03%.
The company raised net proceeds of 3.46 billion yuan from a non-public share issuance in 2022. A portion of these funds is temporarily idle given the implementation timeline of invested projects.
The structured deposits are low-risk with floating returns, and individual products will not exceed 12-month terms to maintain liquidity and capital security. The company said the strategy does not impact ongoing investment projects or alter the original use of raised funds.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Beijing Wantai Biological Pharmacy Enterprise publishes news
Free account required • Unsubscribe anytime